Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Heerboth

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancers|December 7, 2018
Sensitization of Drug Resistant Cancer Cells: A Matter of Combination TherapyMeghan Leary, Sarah Heerboth, Karolina Lapinska, et al.
Epigenomics|February 19, 2013
Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapySibaji Sarkar, Sarah Goldgar, Shannon Byler, et al.
Genetics & Epigenetics|December 17, 2014
Use of epigenetic drugs in disease: an overviewSarah Heerboth, Karolina Lapinska, Nicole Snyder, et al.
Anticancer Research|October 30, 2016
The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer CellsKarolina Lapinska, Genevieve Housman, Shannon Byler, et al.
Cancers|September 9, 2014
Drug resistance in cancer: an overviewGenevieve Housman, Shannon Byler, Sarah Heerboth, et al.
Anticancer Research|December 27, 2017
Cancer Progenitor Cells: The Result of an Epigenetic Event?Karolina Lapinska, Gabriela Faria, Sandra McGonagle, et al.
Anticancer Research|March 6, 2014
Genetic and epigenetic aspects of breast cancer progression and therapyShannon Byler, Sarah Goldgar, Sarah Heerboth, et al.
Genetics & Epigenetics|August 12, 2016
The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological ConsequencesAmber Willbanks, Meghan Leary, Molly Greenshields, et al.
Clinical and Translational Medicine|April 9, 2015
EMT and tumor metastasisSarah Heerboth, Genevieve Housman, Meghan Leary, et al.
Anticancer Research|July 4, 2012
Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitorMegan A Mataga, Shoshana Rosenthal, Sarah Heerboth, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancers|December 7, 2018
Sensitization of Drug Resistant Cancer Cells: A Matter of Combination TherapyMeghan Leary, Sarah Heerboth, Karolina Lapinska, et al.
Epigenomics|February 19, 2013
Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapySibaji Sarkar, Sarah Goldgar, Shannon Byler, et al.
Genetics & Epigenetics|December 17, 2014
Use of epigenetic drugs in disease: an overviewSarah Heerboth, Karolina Lapinska, Nicole Snyder, et al.
Anticancer Research|October 30, 2016
The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer CellsKarolina Lapinska, Genevieve Housman, Shannon Byler, et al.
Cancers|September 9, 2014
Drug resistance in cancer: an overviewGenevieve Housman, Shannon Byler, Sarah Heerboth, et al.
Anticancer Research|December 27, 2017
Cancer Progenitor Cells: The Result of an Epigenetic Event?Karolina Lapinska, Gabriela Faria, Sandra McGonagle, et al.
Anticancer Research|March 6, 2014
Genetic and epigenetic aspects of breast cancer progression and therapyShannon Byler, Sarah Goldgar, Sarah Heerboth, et al.
Genetics & Epigenetics|August 12, 2016
The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological ConsequencesAmber Willbanks, Meghan Leary, Molly Greenshields, et al.
Clinical and Translational Medicine|April 9, 2015
EMT and tumor metastasisSarah Heerboth, Genevieve Housman, Meghan Leary, et al.
Anticancer Research|July 4, 2012
Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitorMegan A Mataga, Shoshana Rosenthal, Sarah Heerboth, et al.
Pageof 2